http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2528093-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86de7d9f2e6454d7c2f6aeaf3b9541b6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9476298fe8fa312832665179e9181cf6 |
| publicationDate | 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2528093-C2 |
| titleOfInvention | Pharmaceutical composition and method of treating acute and chronic respiratory diseases and cough syndrome |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: group of inventions refers to medicine, particularly to therapy, and concerns treating acute and chronic respiratory diseases and cough syndrome. That is ensured by administering a pharmaceutical composition containing activated potentiated antibodies to bradykinin, morphine and histamine. n EFFECT: invention provides the pronounced effect in infectious-inflammatory and allergic cough by the synergetic effect of the ingredients of the composition. n 4 cl, 4 ex, 2 dwg, 5 tbl |
| priorityDate | 2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.